|
WO9200090A1
|
|
Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
|
|
EP0533795A1
|
|
Composition of and treatment with biologically active peptides having d-amino acid residues
|
|
EP0526570A1
|
|
Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
|
|
WO9116066A1
|
|
Composition and treatment with biologically active peptides and toxic cations
|
|
WO9112015A1
|
|
Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
|
|
IL93959D0
|
|
Pharmaceutical compositions comprising biologically active peptides and an antibiotic
|
|
CA2007913A1
|
|
Composition and treatment with peptide combinations
|
|
US5073542A
|
|
CPF peptide compositions and their use in inhibiting growth of target cells or a virus
|
|
US5045531A
|
|
Wound treatment employing biologically active ion channel forming peptides and proteins
|
|
GR1000913B
|
|
Composition and treatment by means of biologically active peptides and certain ions
|
|
ZA8907935B
|
|
Composition and treatment with biologically active peptides and certain anions
|
|
WO9004408A1
|
|
Composition and treatment with biologically active peptides and certain anions
|
|
AU4410989A
|
|
Cpf peptide compositions and uses
|
|
AU3769189A
|
|
Amphiphilic peptides and use thereof
|
